LIVE MARKETS-STOXX suffers, but stays steady across the week

By Reuters News

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

STOXX SUFFERS, BUT STAYS STEADY ACROSS THE WEEK

European stocks are down across sectors and countries as Thursday's tech rout spilled across into the broader market with traders risk-averse and seeking safety elsewhere.

The STOXX 600 .STOXX is down 1%, leaving it more or less unchanged across the week. The FTSE is 1.4% lower and the DAX .GDAXI and CAC 40 .FCHI are down around 1%.

Almost European sectors are in the red, with healthcare names .SXDP down 2.2% and among the biggest decliners after biotech company Genmab's earnings disappointed somewhat. Sales of cancer drug EPKINLY slightly missed estimates, and shares were last down 5%.

Tech shares steadied, and were slightly higher on the day, after posting a 3.2% fall on Thursday, when the chip complex took a hammering. ASML ASML.AS shed 6.5% BE Semiconductor BESI.AS 7% and Soitec SOIT.PA 7%.

All were bouncing back on Friday, and Nasdaq futures are up 1%, but the broader market remained under pressure, with consumer staples, food and beverage and oil and gas stocks all down around 1.5%. .SXCSP, .SXEP, .SX3P

One single stock move to highlight is France's TP TEPRF.PA, down over 16% even after recouping some losses, after the outsourcing firm cut its full-year revenue outlook.

(Sophie Kiderlin)

EARLIER ON LIVE MARKETS:

BEFORE THE BELL: TECH WORRIES CRASH ASHORE IN EUROPE? CLICK HERE

AI'S REALITY CHECK CLICK HERE

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk